Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Visitors trend2W10W9M

2.8000

-0.0600

(-2.10%)

As of 12:26PM EST. Market open.

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	2.8600
Open	2.8600
Bid	2.7800 x 1000
Ask	2.7900 x 800
Day's Range	2.7650 - 2.8600
52 Week Range	1.7950 - 4.5000
Volume	118,991
Avg. Volume	896,573

Market Cap	367.676M
Beta (5Y Monthly)	1.40
PE Ratio (TTM)	28.00
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ORGO

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Organogenesis Holdings Inc.
ORGO: What does Argus have to say about ORGO?ORGANOGENESIS HOLDINGS INC has an Investment Rating of SELL; a target price of $2.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
9 months agoArgus Research